TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy
Cited by 22
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/<i>β</i>-Catenin Signaling Pathways
|Oxidative Medicine and Cellular Longevity|2020|46
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
|Journal of Experimental & Clinical Cancer Research|2018|36
The NEDD4‐1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma
|International Journal of Cancer|2019|35